152 related articles for article (PubMed ID: 90168)
1. Phosphonoformate inhibition of visna virus replication.
Sundquist B; Larner E
J Virol; 1979 Jun; 30(3):847-51. PubMed ID: 90168
[TBL] [Abstract][Full Text] [Related]
2. Phosphonoformate inhibits reverse transcriptase.
Sundquist B; Oberg B
J Gen Virol; 1979 Nov; 45(2):273-81. PubMed ID: 94344
[TBL] [Abstract][Full Text] [Related]
3. Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides.
Frank KB; McKernan PA; Smith RA; Smee DF
Antimicrob Agents Chemother; 1987 Sep; 31(9):1369-74. PubMed ID: 2445282
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of visna virus replication and cytopathic effect in sheep choroid plexus cell cultures by selected anti-HIV agents.
Thormar H; Balzarini J; Debyser Z; Witvrouw M; Desmyter J; De Clercq E
Antiviral Res; 1995 May; 27(1-2):49-57. PubMed ID: 7486958
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of visna virus replication by 2',3'-dideoxynucleosides and acyclic nucleoside phosphonate analogs.
Thormar H; Balzarini J; Holy A; Jindrich J; Rosenberg I; Debyser Z; Desmyter J; De Clercq E
Antimicrob Agents Chemother; 1993 Dec; 37(12):2540-4. PubMed ID: 7509142
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cytomegalovirus late antigens by phosphonoformate.
Wahren B; Oberg B
Intervirology; 1980; 12(6):335-9. PubMed ID: 6244238
[TBL] [Abstract][Full Text] [Related]
7. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
Oberg B
Pharmacol Ther; 1982; 19(3):387-415. PubMed ID: 6201932
[No Abstract] [Full Text] [Related]
8. Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate.
Sandstrom EG; Kaplan JC; Byington RE; Hirsch MS
Lancet; 1985 Jun; 1(8444):1480-2. PubMed ID: 2409414
[TBL] [Abstract][Full Text] [Related]
9. Effect of recombinant human alpha A interferon on Visna virus multiplication in acutely infected ovine cells.
Canivet M; Hurpin C; Rozain F; Tanaka A; Lasneret J; Debons-Guillemin MC; Périès J
J Biol Regul Homeost Agents; 1989; 3(3):122-7. PubMed ID: 2560315
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human immunodeficiency virus reverse transcriptase by 2',3'-dideoxynucleoside triphosphates: template dependence, and combination with phosphonoformate.
Starnes MC; Cheng YC
Virus Genes; 1989 May; 2(3):241-51. PubMed ID: 2474897
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of foscarnet on herpesvirus multiplication in cell culture.
Schnürer J; Oberg B
Arch Virol; 1981; 68(3-4):203-9. PubMed ID: 6268019
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of hepatitis-B-virus DNA polymerase by phosphonoformate: studies on its mode of action.
Hess G; Arnold W; Meyer zum Büschenfelde KH
J Med Virol; 1980; 5(4):309-16. PubMed ID: 6453206
[TBL] [Abstract][Full Text] [Related]
13. Reversible inhibition of cytomegalovirus replication by phosphonoformate.
Wahren B; Oberg B
Intervirology; 1980; 14(1):7-15. PubMed ID: 6259084
[TBL] [Abstract][Full Text] [Related]
14. Maedi-visna virus, a model for in vitro testing of potential anti-HIV drugs.
Salvatori D; Vincenzetti S; Maury G; Gosselin G; Gaubert G; Vita A
Comp Immunol Microbiol Infect Dis; 2001 Apr; 24(2):113-22. PubMed ID: 11247044
[TBL] [Abstract][Full Text] [Related]
15. Resistance of visna virus to interferon.
Carroll D; Ventura P; Haase A; Rinaldo CR; Overall JC; Glasgow LA
J Infect Dis; 1978 Nov; 138(5):614-7. PubMed ID: 213502
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic and therapeutic effects of phosphonoformate against feline leukemia virus in vitro.
Swenson CL; Polas PJ; Cheney CM; Kociba GJ; Mathes LE
Am J Vet Res; 1991 Dec; 52(12):2010-5. PubMed ID: 1724122
[TBL] [Abstract][Full Text] [Related]
17. Mode of action of phosphonoformate as an anti-herpes simplex virus agent.
Cheng YC; Grill S; Derse D; Chen JY; Caradonna SJ; Connor K
Biochim Biophys Acta; 1981 Jan; 652(1):90-8. PubMed ID: 6260189
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of DNA polymerase and RNase H activities of the reverse transcriptase by phosphonoformate.
Margalith M; Falk H; Panet A
Mol Cell Biochem; 1982 Mar; 43(2):97-103. PubMed ID: 6178013
[TBL] [Abstract][Full Text] [Related]
19. Marked inhibitory activity of masked aryloxy aminoacyl phosphoramidate derivatives of dideoxynucleoside analogues against visna virus infection.
Balzarini J; Cahard D; Wedgwood O; Salgado A; Velázquez S; Yarnold CJ; De Clercq E; McGuigan C; Thormar H
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):296-302. PubMed ID: 9525429
[TBL] [Abstract][Full Text] [Related]
20. Increased efficacy of phosphonoformate and phosphonoacetate inhibition of herpes simplex virus type 2 replication by encapsulation in liposomes.
Szoka FC; Chu CJ
Antimicrob Agents Chemother; 1988 Jun; 32(6):858-64. PubMed ID: 2843083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
